Skip to main content
Signal8

Lunai Bioworks Inc. (LNAI)

Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Lunai Bioworks Inc. logo

Lunai Bioworks Inc.

OTC:LNAIOTC (delisted from Nasdaq, Form 25 effective Nov 12, 2026)Healthcare
+0.00%$0.1648
Mkt Cap$830K
EV-
Float4.88M
O/S5.03M
VOL1.27M sh
$ Vol$195K
RVOL0.86×
Inst Own3.8%
SI0.4%
Net Cash/Sh-
Dilution
Lunai Bioworks Inc. logoOTC:LNAI$0.1648+0.00%

Lunai Bioworks Inc. (LNAI) dilution facts from SEC filings

Snapshot as of Jun 30, 2026, built from 29 SEC filings.

Shelf registration
None on file in the filings reviewed
At-the-market (ATM) program
No active program in the filings reviewed
Warrants outstanding
3 warrant series recorded as outstanding
Most recent offering
Offering, priced Sep 2, 2026
Source: 10-K filed Oct 13, 2026

Check another stock for dilution

Facts as recorded in the company's SEC filings. The full snapshot, with instrument terms, share counts and history, is part of Signal8 Pro.

Unlock with Signal8 Pro